Clinical Trial Update: Bioequivalence of Two Tablet Forms of MK0974 (0974-045) [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 bioequivalence study comparing two tablet forms of MK0974 for migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MK0974

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 1 | Status: COMPLETED